{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:50:41Z","timestamp":1792626641524,"version":"4.5.0"},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,4,15]]},"DOI":"10.2169\/internalmedicine.8173-21","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T22:19:03Z","timestamp":1633385943000},"page":"1237-1240","source":"Crossref","is-referenced-by-count":6,"title":["Seizure Deterioration with Increased Levetiracetam Blood Concentration during the Postpartum Period in Refractory Temporal Lobe Epilepsy"],"prefix":"10.2169","volume":"61","author":[{"given":"Mai","family":"Kikumoto","sequence":"first","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichiro","family":"Neshige","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan"},{"name":"Epilepsy Center, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Shishido","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan"},{"name":"Epilepsy Center, Hiroshima University Hospital, Japan"},{"name":"Department of Neurology, Hiroshima City Asa Citizens Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Ueno","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan"},{"name":"Epilepsy Center, Hiroshima University Hospital, Japan"},{"name":"Department of Neurology, Hiroshima City Hiroshima Citizens Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Iida","sequence":"additional","affiliation":[{"name":"Epilepsy Center, Hiroshima University Hospital, Japan"},{"name":"Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan"},{"name":"Epilepsy Center, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Westin AA, Reimers A, Helde G, Nakken KO, Brodtkorb E. Serum concentration\/dose ratio of levetiracetam before, during and after pregnancy. Seizure 17: 192-198, 2008.","DOI":"10.1016\/j.seizure.2007.11.027"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Nakken KO, Eriksson AS, Lossius R, Johannessen SI. A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy. Seizure 12: 42-46, 2003.","DOI":"10.1016\/S1059131102001723"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ross RT, Mathiesen R. Volitional and emotional supranuclear facial weakness. N Engl J Med 338: 1515, 1998.","DOI":"10.1056\/NEJM199805213382105"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Szucs A, Clemens Z, Jakus R, et al. The risk of paradoxical levetiracetam effect is increased in mentally retarded patients. Epilepsia 49: 1174-1179, 2008.","DOI":"10.1111\/j.1528-1167.2008.01585.x"},{"key":"5","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1111\/j.1528-1157.1998.tb05116.x","volume":"39","author":"CE Elger","year":"1998","unstructured":"5. Elger CE, Bauer J, Scherrmann J, Widman G. Aggravation of focal epileptic seizures by antiepileptic drugs. Epilepsia 39: S15-S18, 1998.","journal-title":"Epilepsia","ISSN":"https:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1528-1167.2007.01329_1.x","volume":"49","author":"AK Thacker","year":"2008","unstructured":"6. Thacker AK, Misra P, Gupta PP. Exacerbations of seizures by levetiracetam. Epilepsia 49: 177, 2008.","journal-title":"Epilepsia","ISSN":"https:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Cook MJ, Karoly PJ, Freestone DR, et al. Human focal seizures are characterized by populations of fixed duration and interval. Epilepsia 57: 359-368, 2016.","DOI":"10.1111\/epi.13291"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kahane P, Hoffmann D, Minotti L, Berthoz A. Reappraisal of the human vestibular cortex by cortical electrical stimulation study. Ann Neurol 54: 615-624, 2003.","DOI":"10.1002\/ana.10726"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Cereghino JJ, Biton V, Abou-Khalil B, et al. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 55: 236-242, 2000.","DOI":"10.1212\/WNL.55.2.236"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wright C, Downing J, Mungall D, et al. Clinical pharmacology and pharmacokinetics of levetiracetam. Front Neurol 4: 1-6, 2013.","DOI":"10.3389\/fneur.2013.00192"},{"key":"11","unstructured":"11. L\u00fcders HO, Najm I, Nair D, Widdess-Walsh P, Bingman W. The epileptogenic zone: general principles. Epileptic Disord 8: S1-S9, 2006."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/8\/61_8173-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:12:14Z","timestamp":1715231534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/8\/61_8173-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8173-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,15]]},"article-number":"8173-21"}}